Conventional medicine saves lives, but innovative and integrative approaches can extend and enhance them
Top Oncologist Blows Whistle: ‘Ivermectin Proven More Effective Than Chemotherapy’
Get link
Facebook
X
Pinterest
Email
Other Apps
By
Editorial Team
-
Ivermectin
has proven more effective than chemotherapy, without any of the debilitating
side-effects, according to world-renowned Canadian oncologist Dr. William Makis
who cited a major international cancer study to make his case.
Dr.
Makis asserts that the study’s findings call for a profound shift in the
treatment of advanced breast cancer, as the evidence shows Ivermectin could
significantly outperform traditional chemotherapy.
According to Dr.
Makis, the anti-parasitic drug Ivermectin has shown staggering results,
outperforming the widely-used chemotherapy drug Paclitaxel and destroying cancer
stem cells — those responsible for metastasis and recurrence.
Dr. Makis
based
his urgent plea on a 2017 study by Mexican researchers, which should have
fundamentally changed breast cancer treatment.
Published
as “Ivermectin as an Inhibitor of Cancer Stem Cells,” the study reveals how
Ivermectin annihilates breast cancer stem cells, offering new hope for patients
battling advanced stages of the disease.
Cancer stem cells (CSCs) are a small but powerful subpopulation of cells
within a tumor. Unlike the bulk of tumor cells, CSCs possess the ability to
self-renew indefinitely and are largely responsible for metastasis — the
spread of cancer to other parts of the body — and recurrence after
treatment.
Traditional chemotherapy treatments, like Paclitaxel,
primarily target bulk tumor cells, leaving CSCs untouched and allowing the
cancer to return or spread.
Related: Ivermectin Cancer Success Stories: Case Series Compilation (2025)
In 2009, researchers from MIT and Harvard discovered that another
anti-parasitic drug, Salinomycin, could reduce breast cancer stem cells by
more than 100-fold compared to chemotherapy.
Building on this
discovery, the Mexican researchers identified Ivermectin as the molecule most
closely resembling Salinomycin, after screening 1,623 compounds.
The
study found that Ivermectin not only killed breast cancer stem cells but did
so far more effectively than chemotherapy.
According to the researchers, “Ivermectin preferentially inhibits the
viability of Cancer Stem Cell-enriched populations compared with the total
cell population. The opposite pattern was observed with paclitaxel treatment.”
Key Findings:
Ivermectin outperforms chemotherapy (Paclitaxel): It targets the cancer
stem cells that are resistant to traditional treatments.
Ivermectin destroys Cancer Stem Cells: These stem cells are responsible
for cancer treatment failure, metastasis, and recurrence, making
Ivermectin a powerful tool in preventing cancer from spreading or
returning.
Ivermectin reduces expression of “stemness genes”: These genes are highly
expressed in cancer stem cells, and downregulating them weakens the
cancer’s ability to regenerate.
The study also highlights Ivermectin’s long-standing safety record, having
been used to treat millions of patients with parasitic diseases like
onchocerciasis. Given its established safety profile, Ivermectin is a strong
candidate for repurposing in cancer therapy.
Despite these
remarkable findings, Ivermectin is not widely used to treat breast cancer.
Dr.
Makis suggests that the answer lies in systemic barriers within the medical
and pharmaceutical industries. The potential of Ivermectin to outperform
chemotherapy challenges the current cancer treatment model, which heavily
relies on expensive and less effective drugs.
According to Dr.
Makis and the 2017 study, Ivermectin should be given to all advanced breast
cancer patients. Its ability to target and eliminate cancer stem cells could
significantly reduce the risks of treatment failure, metastasis, and
recurrence — offering a powerful new approach to battling this deadly
disease.
So, why isn’t Ivermectin being used? As Dr. Makis says, “I
think we all know the answer.”
About the Author: Baxter Dmitry is a writer at The People's Voice. He
covers politics, business and entertainment. Speaking truth to power since he
learned to talk, Baxter has travelled in over 80 countries and won arguments
in every single one. Live without fear.
Please do not consider this guide as personal medical
advice, but as a recommendation for use by professional
providers. Consult with your doctor and discuss with
her/him.
Our aim here isn't to replace your doctors' advice. It is
intended as a sharing of knowledge and information. Do take
note that most treatments are not 100% protective or
curative against cancer. It's a continuous struggle between
the immune system and the cancer cells. Cancer treatments
are meant to assist the immune system in this battle.
Cancer treatment should be part of a multi-modal approach
in order to provide the best possible outcome. Diet and
lifestyle changes are meant to run alongside conventional
treatment. They are complementary, not alternative. That
said, there is no miracle diet or treatment that can cure
all cancers.
In 2016, Joe Tippens was diagnosed with non-small-cell lung cancer with extensive metastatic disease. At the advice of a veterinarian friend, he took Fenbendazole together with nanocurcumin, and three months after starting these drugs his PET scan was completely clear.
Below is a modified version of the Joe Tippens protocol, a synergistic combination of fenbendazole, ivermectin and nutraceuticals, updated based on the ivermectin and mebendazole based protocol published in the Journal of Orthomolecular Medicine (2024):
Ivermectin (24 mg, 6 days a week) or in the case of severe aggresive cancers up to 1mg/kg/day (6 days a week).
Mebendazole (Dose of 200 - 400 mg/day) or Fenbendazole, commonly taken at 300 mg for six days a week, with doses increasing to up to 1 gram in cases of aggressive cancers.
Diet and Lifestyle: Eliminate sugar consumption as supported by the BMJ 2023 umbrella review, which recommends reducing free and added sugars to below 25 g/day and limiting sugar-sweetened beverages to less than one serving per week to reduce adverse health effects. Adopt a whole-food diet and avoid ultra-processed foods, as recommended by the BMJ 2024 guidelines. Additionally, prioritise adequate sleep and effective stress management to support overall health.
*Notes:
Please note that this protocol now includes the vital Vitamin D addition, with the one day off for the fenbendazole administration. This protocol represents the most comprehensive and cutting edge repurposed drug and vitamin treatment approach to date.
If you are taking ivermectin and mebendazole, you might not need fenbendazole. Consult your doctor.
Vitamin E: Removed from the protocol (Joe Tippens, July 22, 2020) due to interactions (e.g., with blood thinners).
My brother was diagnosed in 2014 for GIST. He has had his stomach removed, part of his esophagus and a cholestectomy. He has been on Gleevec since 2014. He has a tumor in his liver and hip bone. Will Ivermectin or Fen. Work for him?
its absolutely worth a shot ! Check out the YouTube channel "Dr. John Campbell". He has many videos covering the use of ivermectin for different types of cancer. You can also look up the website "my Cancer Story. rocks" to read about peoples experiences healing their cancers. Praying for your brother and family <3
Medically Reviewed by: OneDayMD Editorial Team Last Updated: May 2026 Dr. William Makis MD (McGill Medicine, 110+ peer-reviewed publications) has treated a large volume of cancer patients using repurposed drugs since 2023 and has documented outcomes publicly on Substack and X. This continuously updated 2026 guide compiles Dr. Makis's latest protocols (from his Substack, X posts through 2026, and direct patient correspondence). We cross-reference his exact dosages, schedules, combinations, safety data, sourcing, and real patient outcomes (anonymized but verifiable on his channels). Important Disclaimer: This content is for educational purposes only and does not constitute medical advice. Ivermectin is used off-label for cancer treatment. Always consult with a knowledgeable physician whom you trust to manage your health. Individual results may vary. Do not self-medicate with ivermectin without proper bloodwork and medical monitoring, as misuse can lead to serious side effects and dru...
Medically Reviewed by: OneDayMD Editorial Team Last Updated: May 2026 Table of Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories (126 cases) Brain Cancer (including Glioblastoma) (129 cases) Bladder Cancer Success Stories (including kidney cancer) (32 cases) Cervical Cancer (6 cases) Colorectal Cancer (including Appendix cancer) (82 cases) Esophageal and Stomach cancer (23 cases) Endometrial Cancer (11 cases) Gastric (Stomach) cancer (see Esophageal and Stomach Cancer ) Head and Neck Cancer (17 cases) Kidney Cancer Case Series (including urinary (urothelial) bladder cancer) Liver and Bile Duct Cancer (Hepato-biliary system) (9 cases) Lung Cancer (46 cases) Leukemia (10 cases) Lymphoma (25 cases) Melanoma (refer to Skin ...
If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories and a recent peer-reviewed publication, " Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients : Results from a Prospective Observational Cohort ( Anticancer Research 2026 )" We have seen tremendous demand for some sort of guide on how to use fenbendazole for cancer as there is also tremendous confusion both from the healthcare and non-healthcare communities. Joe Tippens founded the protocol (1) after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scienti...
Medically Reviewed by: OneDayMD Editorial Team Last Updated: April 2026 In September 2024, a first-of-its-kind protocol utilizing ivermectin, fenbendazole, and mebendazole for cancer treatment was peer-reviewed and officially published in the Journal of Orthomolecular Medicine . Led by researchers Dr. Ilyes Baghli, Dr. Pierrick Martinez, and FLCCC's Dr. Paul Marik, the protocol applies antiparasitic drugs — originally developed to combat parasites — to cancer treatment, building on emerging preclinical and clinical evidence of their anticancer properties. This trio of repurposed drugs has been shown to disrupt the growth of cancer cells, particularly by targeting microtubules, the essential structures that allow cancer to multiply uncontrollably. What makes this protocol even more potent is the synergistic effect when these drugs are used together, creating a powerful new affordable weapon against cancer. Journal of Orthomolecular Medicine 2024 Targeting the Mitochondrial-Stem Cel...
Quick Summary: DMSO (Dimethyl Sulfoxide) is a naturally occurring compound with decades of research behind its use as an anti-inflammatory, analgesic, and cellular-protective agent. FDA-approved for interstitial cystitis, it has been used off-label by athletes, physicians, and patients for musculoskeletal injuries, chronic pain, wound healing, and more. This guide covers what DMSO is, how it works, the evidence for its key uses, safety considerations, dosing guidance, and where to find practitioners who use it. All off-label uses are experimental. Consult a qualified healthcare provider before use. A Patient Story: From Lung Transplant List to Clear CT Scans In 2022, Erica Eyres, a vigorous fifty-six-year-old aerobics instructor who had struggled to breathe, was given “absolutely devastating” news: She might need a lung transplant. She had never smoked, ran cross-country track in high school, and was a personal trainer for years, but, by 2024, a transplant assessment was arranged. “I d...
Ivermectin Resources I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers. These protocols, referred to as the “Dr. Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer. Updated version I have an article and a video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose Ivermectin and Cancer . 2025 - 2026 studies on ivermectin for cancer Clinical Hulscher et al - Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients : Results from a Prospective Observational Cohort (2026) Yuan Yuan et al (Cedars-Sinai Medical Center) - A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in p...
Introduction This article discusses dosage considerations and key factors regarding the use of ivermectin in cancer treatment. Commonly available information about ivermectin dosages is often inaccurate when applied to potential cancer-related uses. Many sources cite standard dosages recommended by Merck for treating parasitic infections, rather than dosages studied specifically in the context of cancer research. The anti-parasitic dosage is not as effective for people looking for a dosage against cancer. Dosage will need to be adjusted according to the current weight, the type of Cancer, the stage and grade of the Cancer and the health of the liver. Ivermectin dosage should also be based on ivermectin cancer studies. Multiple factors are considered including studies including ivermectin for cancer, anecdotal studies and case series, the aggressiveness of the cancer type and the cancer stage. It also takes into account the types of medications the person uses. For example, i...
Key Takeaways (2026) Ivermectin remains an FDA-approved prescription drug for humans (e.g., parasitic infections like strongyloidiasis and onchocerciasis). It is NOT universally over-the-counter (OTC) in the U.S.—but state-level laws are rapidly changing . As of 2025–2026, some states allow pharmacist dispensing or OTC access , while others still require a prescription. ( Wdam ) Availability is inconsistent by location , even though there is no nationwide shortage . Current Legal Status (U.S., 2026) Federal Level Ivermectin tablets are still classified as a prescription drug for human use under FDA regulation. ( MedPath ) Doctors may legally prescribe it off-label (common practice in U.S. medicine). State-Level Changes (Major 2025–2026 Shift) Several states have passed or proposed laws to expand access: States allowing easier access Idaho – OTC availability without prescription Arkansas, Tennessee ...
Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), pinworms, aelurostrongylus, paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, as well as seals. (2) Fenbendazole, has garnered attention for its potential use in humans. The Fenbendazole Cancer Protocol gained rapid interest over the past years following some fenbendazole advanced cancer success stories (more than 500 case reports). Joe Tippens founded the protocol after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different m...
A research group from Mexico investigated Ivermectin in Cancer. This is the first study that has tested as many as 28 Cancer types with Ivermectin. Paper: 2020 (Juarez et al) - Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug. Ivermectin was tested at 2mg/kg/day which translates to roughly 5uM in vitro concentration. The most sensitive cancer cell lines were: 1. Ovarian 2. Breast 3. Glioblastoma 4. Lung Cancer 5. Colon Cancer 6. Uterine SCC 7. hepatocellular 8. breast TNBC 9. Pancreatic 10. Endometrial. Least sensitive were: 1. osteosarcoma 2. gastric 3. melanoma Although lymphoma and leukemia cell lines appear to be more resistant to Ivermectin, Ivermectin has a significant impact on those cells' ability to form colonies. So yes, Ivermectin is useful against BOTH lymphomas and leukemias. Ivermectin also goes after CANCER STEM CELLS, which tend to be resistant to chemotherapy: ...
.png)
My brother was diagnosed in 2014 for GIST. He has had his stomach removed, part of his esophagus and a cholestectomy. He has been on Gleevec since 2014. He has a tumor in his liver and hip bone. Will Ivermectin or Fen. Work for him?
ReplyDeleteits absolutely worth a shot ! Check out the YouTube channel "Dr. John Campbell". He has many videos covering the use of ivermectin for different types of cancer. You can also look up the website "my Cancer Story. rocks" to read about peoples experiences healing their cancers. Praying for your brother and family <3
DeleteHi does this method kill colon cancer?
ReplyDeleteYes. I've heard that this treatment is very effective for colon cancer
DeleteDoes this treatment Ivermectin & Fenbendazole cure type 1 diabetes?
ReplyDeleteI’ve heard you need to take a binder when taking this for the die off? Is this correct?
ReplyDelete